Sequencing of Radium-223 and Docetaxel in Symptomatic Bone-only Metastatic Castration-resistant Prostate Cancer

Clinical trial NCT03230734 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT03230734

Sponsor

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2017-09-01

Primary completion

2025-07-01

Enrollment

70

View on ClinicalTrials.gov